Upregulation of ECT2 Predicts Adverse Clinical Outcomes and Increases 5-Fluorouracil Resistance in Gastric Cancer Patients

CONCLUSION: Upregulation of ECT2 can predict adverse clinical outcomes and increase 5-FU resistance in GC patients.PMID:34367280 | PMC:PMC8337122 | DOI:10.1155/2021/2102890

Source: Journal of Oncology - August 9, 2021 Category: Cancer & Oncology Authors: Hua Zhang Yuan Geng Chunhui Sun Jin Yu Source Type: research